A novel inhibitor of advanced glycation and endoplasmic reticulum stress reduces infarct volume in rat focal cerebral ischemia

Takizaw, Shunya;Izuhara, Yuko;Kitao, Yasuko;Hori, Osamu;Miyata, Toshio;et.al.
(2007) Brain Research — Vol. 1183, p. 124-137 (2007)

Files

pdfdocument.pdf
  • Restricted Access
  • Adobe PDF
  • 1.74 MB

Details

Authors
  • Takizaw, Shunya
    Author
  • Izuhara, Yuko
    Author
  • Kitao, Yasuko
    Author
  • Hori, Osamu
    Author
  • Van Ypersele de Strihou, CharlesUCLouvain
    Author
  • Miyata, Toshio
    Author
Show more
Abstract
We have developed a novel, non-toxic inhibitor of advanced glycation and oxidative stress, TM2002, devoid of effect on blood pressure. In transient focal ischemia, TM2002 significantly decreased infarct volume compared with vehicle (79.5 +/- 18.7 vs. 183.3 +/- 22.9 mm(3), p < 0.01). In permanent focal ischemia, TM2002 (2.79, 5.58, and 11.16 mg/kg twice a day) dose-dependently reduced infarct volume (242.1 +/- 32.3, 201.3 +/- 15.1, and 171.3 +/- 15.2 mm(3), respectively), and improved neurological deficits. Reduction of infarct volume is demonstrable, provided that TM2002 was administered within 1.5 h after the occlusion. To unravel TM2002's mechanism of action, we examined its in vitro effect on endoplasmic reticulum (ER) stress, using aortic smooth muscle cells isolated from ORP 150(+/-) mice and F9 Herp null mutated cells. Cell death induced by ER stress (tunicamycin or hypoxia) was dose-dependently prevented by TM2002. In vivo immunohistochemical study demonstrated a significant reduction of ORP- and TUNEL-positive apoptotic cells, especially in the penumbra. Inhibition of advanced glycation and oxidative stress was confirmed by a significantly reduced number of cells positive for advanced glycation end products and heme oxygenase-1. TM2002 reduced the levels of protein carbonyl formation in ischemic caudate. The efficacy of TM2002 is equivalent to that of a known neuroprotective agent, NXY-059. In conclusion, TM2002 significantly ameliorates ischemic cerebral damage through reduction of ER stress, advanced glycation, and oxidative stress, independently of blood pressure lowering. (c) 2007 Published by Elsevier B.V.
Affiliations

Citations

Takizaw, S., Izuhara, Y., Kitao, Y., Hori, O., Ogawa, S., Morita, Y., Takagi, S., Van Ypersele de Strihou, C., & Miyata, T. (2007). A novel inhibitor of advanced glycation and endoplasmic reticulum stress reduces infarct volume in rat focal cerebral ischemia. Brain Research, 1183, 124-137. https://doi.org/10.1016/j.brainres.2007.07.006 (Original work published 2007)